• SENSEX
    NIFTY 50
Market

As the economy starts unlocking, Angel Broking lists its top picks

Updated : 2020-09-03 13:44:19

With the government gradually providing major relaxations in the ‘Unlocking phase’, analysts maintain their positive stance on the recovery theme given expectations of further improvement in economic activities along with the possibility of a vaccine sometimes by end of 2020 or early 2021. Angel Broking said that further easing of restrictions will help economic recovery and be positive for the markets. Here are the top picks among various sectors from the brokerage:

 Reliance Industries  | TP: Rs 2,366 | Digital and retail business to be a key growth driver for the company. Spin-off and investment by a strategic investor in O2C business is key monitorable, the brokerage said.
Reliance Industries | TP: Rs 2,366 | Digital and retail business to be a key growth driver for the company. Spin-off and investment by a strategic investor in O2C business is key monitorable, the brokerage said.
 Britannia Industries  | TP: Rs 4,220 | Expect healthy growth and profitability on the back of an increase in market share, wide distribution network and new product launches.
Britannia Industries | TP: Rs 4,220 | Expect healthy growth and profitability on the back of an increase in market share, wide distribution network and new product launches.
 Endurance Technologies  | TP: Rs 1,297 | Pent up demand and consumer preference for personal transportation is positive for domestic 2W companies, which would benefit Endurance, Angel Broking said.
Endurance Technologies | TP: Rs 1,297 | Pent up demand and consumer preference for personal transportation is positive for domestic 2W companies, which would benefit Endurance, Angel Broking said.
 IDFC First Bank  | TP: Rs 36 | Angel Broking believes efforts to built retail liability franchise, fresh capital infusion and provision taken on the wholesale book will help to tide over this difficult time.
IDFC First Bank | TP: Rs 36 | Angel Broking believes efforts to built retail liability franchise, fresh capital infusion and provision taken on the wholesale book will help to tide over this difficult time.
 Cholamandalam Investment  | TP: Rs 280 | The brokerage believes diversified product mix will help capture growth in LCV, tractor and 2W segment. Adequate capital adequacy and declined trend in Cost of fund and strong parentage to provide comfort.
Cholamandalam Investment | TP: Rs 280 | The brokerage believes diversified product mix will help capture growth in LCV, tractor and 2W segment. Adequate capital adequacy and declined trend in Cost of fund and strong parentage to provide comfort.
 Persistent Systems  | TP: Rs 1,276 | Company has won deals worth $150 million in Q1Y21 and management has highlighted a strong deal pipeline which will drive growth in H2FY21. (Image: Company)
Persistent Systems | TP: Rs 1,276 | Company has won deals worth $150 million in Q1Y21 and management has highlighted a strong deal pipeline which will drive growth in H2FY21. (Image: Company)
 Zensar Technologies  | TP: Rs 204 | We expect strong sequential growth in Q2FY21 driven by ramp up of existing projects and limited exposure to sectors like retail and Oil & gas, the brokerage said. (Image: Company)
Zensar Technologies | TP: Rs 204 | We expect strong sequential growth in Q2FY21 driven by ramp up of existing projects and limited exposure to sectors like retail and Oil & gas, the brokerage said. (Image: Company)
 Alembic Pharmaceuticals  | TP: Rs 1,400 | Expect growth in demand for Indian API to continue along with recovery in the domestic market and growth in US markets led by new launches. (Image: Reuters)
Alembic Pharmaceuticals | TP: Rs 1,400 | Expect growth in demand for Indian API to continue along with recovery in the domestic market and growth in US markets led by new launches. (Image: Reuters)
 Metropolis Healthcare  | TP: Rs 2,156 | We are positive on the company given expected long term growth rates of ~15% CAGR, stable margins profile and moderating competitive intensity, Angel broking said.
Metropolis Healthcare | TP: Rs 2,156 | We are positive on the company given expected long term growth rates of ~15% CAGR, stable margins profile and moderating competitive intensity, Angel broking said.
Live TV

recommended for you

Ask Our Experts CNBC TV18

Advertisement